News & Updates

Omega-3-enriched diet cuts headache days

20 Aug 2021 by

Consuming a diet enriched with the EPA and DHA* omega-3 fatty acids leads to less frequent and milder headache in patients with migraine, according to a double-blind, randomized study.

Omega-3-enriched diet cuts headache days

20 Aug 2021

Vision impairment ups risks for dementia, cognitive decline in older adults

20 Aug 2021 by

Older adults with vision impairment are at higher risk of both dementia and cognitive impairment, according to a study.

Vision impairment ups risks for dementia, cognitive decline in older adults

20 Aug 2021

Short sleep duration in midlife may increase risk of dementia in later life

19 Aug 2021 by

Midlife adults aged between 50 and 70 years who reported a short sleep duration of ≤6 hours/night had an increased risk of developing dementia later in life, according to a study presented at AAIC 2021.

Short sleep duration in midlife may increase risk of dementia in later life

19 Aug 2021

Is keto neuroprotective in individuals with impaired cognition?

18 Aug 2021 by

Two studies presented at AAIC 2021 showed a potential neuroprotective effect of a ketogenic supplement or diet: In one study, consumption of a keto drink was associated with improvements in dorsal attention network (DAN) functional connectivity in mild cognitive impairment (MCI). Another study showed the keto diet’s potential to improve aberrant default mode network (DMN) connectivity patterns in adults at risk for Alzheimer’s disease (AD).

Is keto neuroprotective in individuals with impaired cognition?

18 Aug 2021

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

New drug applications approved by US FDA as of 01-15 August 2021 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 August 2021)

18 Aug 2021

Age does not factor in tolerability, safety of lasmiditan for migraine

17 Aug 2021

The tolerability and safety of lasmiditan for the acute treatment of migraine attacks in older patients are consistent with those observed in younger patients, according to a post-hoc analyses of previous studies.

Age does not factor in tolerability, safety of lasmiditan for migraine

17 Aug 2021

Better air quality tied to lower dementia risk

14 Aug 2021 by

Improved air quality was associated with a slower cognitive decline and a lower risk of developing dementia, according to studies presented at AAIC 2021.

Better air quality tied to lower dementia risk

14 Aug 2021

Fibromyalgia patients also show increased sensitivity to mild stimuli

14 Aug 2021

The hypersensitivity of patients with fibromyalgia does not appear to be limited to painful stimuli but also to other stimuli such as sound, as reported in a study.

Fibromyalgia patients also show increased sensitivity to mild stimuli

14 Aug 2021

New study highlights global prevalence of young-onset dementia

13 Aug 2021 by

A new systematic review and meta-analysis presented at AAIC 2021 has hinted at a high prevalence of young-onset dementia (YOD) worldwide.

New study highlights global prevalence of young-onset dementia

13 Aug 2021

Concomitant antidementia drug use does not affect pimavanserin safety, PK profile

13 Aug 2021 by

In patients with neurodegenerative and/or neurovascular disease (NDD) and dementia-related psychosis (DRP), concomitant antidementia medications (cADMs) used alongside the selective serotonin receptor modulating agent pimavanserin did not adversely impact its safety and pharmacokinetic (PK) profile, according to data presented at AAIC 2021.

Concomitant antidementia drug use does not affect pimavanserin safety, PK profile

13 Aug 2021

News & Updates

Filter by Specialty:

Specialty:

Omega-3-enriched diet cuts headache days

Omega-3-enriched diet cuts headache days

Vision impairment ups risks for dementia, cognitive decline in older adults

Vision impairment ups risks for dementia, cognitive decline in older adults

Short sleep duration in midlife may increase risk of dementia in later life

Short sleep duration in midlife may increase risk of dementia in later life

Is keto neuroprotective in individuals with impaired cognition?

Is keto neuroprotective in individuals with impaired cognition?

Original New Drug Application Approvals by US FDA (01-15 August 2021)

Original New Drug Application Approvals by US FDA (01-15 August 2021)

Age does not factor in tolerability, safety of lasmiditan for migraine

Age does not factor in tolerability, safety of lasmiditan for migraine

Better air quality tied to lower dementia risk

Better air quality tied to lower dementia risk

Fibromyalgia patients also show increased sensitivity to mild stimuli

Fibromyalgia patients also show increased sensitivity to mild stimuli

New study highlights global prevalence of young-onset dementia

New study highlights global prevalence of young-onset dementia

Concomitant antidementia drug use does not affect pimavanserin safety, PK profile

Concomitant antidementia drug use does not affect pimavanserin safety, PK profile